v3.22.2.2
OTHER LONG-TERM LIABILITIES - Narrative (Details)
$ / shares in Units, € in Thousands, $ in Thousands
12 Months Ended
Dec. 21, 2021
CAD ($)
$ / shares
Dec. 20, 2021
$ / shares
Sep. 08, 2021
$ / shares
Apr. 06, 2021
CAD ($)
$ / shares
Aug. 31, 2022
CAD ($)
shares
Aug. 31, 2021
CAD ($)
shares
Sep. 21, 2021
shares
Oct. 10, 2018
EUR (€)
Disclosure of contingent liabilities [line items]                
Liabilities         $ 69,049 $ 74,212    
Issued share capital (in shares) | shares         313,815,503 298,786,023    
Weighted average price (in CAD per share) | $ / shares $ 2.53              
Edibles and Infusion Corporation                
Disclosure of contingent liabilities [line items]                
Contingent share consideration       $ 13,000        
Issued share capital (in shares) | shares             1,039,192  
Volume-weighted average TSX listed share price based period     5 days          
Weighted average price (in CAD per share) | $ / shares     $ 3.37 $ 4.36        
EIC share purchase agreement milestone, share consideration         $ 3,500      
Laurentian                
Disclosure of contingent liabilities [line items]                
Contingent share consideration $ 6,996              
Volume-weighted average TSX listed share price based period 5 days              
Weighted average price (in CAD per share) | $ / shares $ 2.53 $ 2.39            
Contingent consideration | Edibles and Infusion Corporation                
Disclosure of contingent liabilities [line items]                
Liabilities         7,000 $ 9,038    
Revaluation of Warrants         1,462 3,789    
Contingent consideration | Laurentian                
Disclosure of contingent liabilities [line items]                
Liabilities $ 6,996       2,913      
Revaluation of Warrants         4,083      
Contingent consideration | Alpha Cannabis Pharma Gmbh                
Disclosure of contingent liabilities [line items]                
Liabilities         $ 0 0   € 875
Revaluation of Warrants           $ 231